Application of transcatheter aortic valve replacement in patients with bicuspid aortic valve stenosis

Author: Yi-jun YAO ¹ ; Yuan-wei-xiang OU ¹ ; Zhen-gang ZHAO ¹ ; Mao CHEN ¹
Author Information

1. Department of Cardiology, West China Hospital, Sichuan University Chengdu 610041, China
Publication Type:Journal Article
Keywords: TAVR; aortic valve stenosis; bicuspid aortic valve
From: Chinese Journal of Practical Internal Medicine 2019;39(07):592-595
CountryChina
Language:Chinese
Abstract: Bicuspid aortic valve stenosis(BAVs) is a relative contraindication for transcatheter aortic valve replacement(TAVR) because of its abnormal anatomical structures and pathological characteristics that result in a lower device success rate in BAVs than that in patients with tricuspid aortic valve. However, with the optimization of TAVR strategies and the application of new-generation devices,the effect of TAVR treatment on BAVs patients has been improved. Thus, the article is to introduce the characteristics of BAVs and the progress of TAVR in treatment of BAVs.